NASDAQ:NAOV - Nasdaq - US63008J6038 - Common Stock - Currency: USD
NASDAQ:NAOV (2/21/2025, 11:35:01 AM)
0.3895
+0.01 (+2.5%)
The current stock price of NAOV is 0.3895 USD. In the past month the price decreased by -18.95%. In the past year, price decreased by -61.5%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.93 | 234.33B | ||
ISRG | INTUITIVE SURGICAL INC | 82.6 | 215.93B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.99 | 155.35B | ||
SYK | STRYKER CORP | 31.77 | 147.63B | ||
MDT | MEDTRONIC PLC | 16.82 | 115.20B | ||
BDX | BECTON DICKINSON AND CO | 16.41 | 65.56B | ||
EW | EDWARDS LIFESCIENCES CORP | 28.32 | 43.76B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.36 | 41.77B | ||
IDXX | IDEXX LABORATORIES INC | 40.5 | 37.31B | ||
DXCM | DEXCOM INC | 54.05 | 34.84B | ||
RMD | RESMED INC | 26.26 | 34.09B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.36 | 23.83B |
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 10 full-time employees. The company went IPO on 2015-04-24. The firm develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
NANOVIBRONIX INC
969 Pruitt Ave,
Tyler TEXAS 10523 US
CEO: Brian Murphy
Employees: 13
Company Website: https://nanovibronix.com/
Investor Relations: http://ir.nanovibronix.com
Phone: 19142333004
The current stock price of NAOV is 0.3895 USD. The price increased by 2.5% in the last trading session.
The exchange symbol of NANOVIBRONIX INC is NAOV and it is listed on the Nasdaq exchange.
NAOV stock is listed on the Nasdaq exchange.
NANOVIBRONIX INC (NAOV) has a market capitalization of 2.39M USD. This makes NAOV a Nano Cap stock.
NANOVIBRONIX INC (NAOV) currently has 13 employees.
NANOVIBRONIX INC (NAOV) has a resistance level at 0.49. Check the full technical report for a detailed analysis of NAOV support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NAOV does not pay a dividend.
NANOVIBRONIX INC (NAOV) will report earnings on 2025-04-07.
NANOVIBRONIX INC (NAOV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.25).
The outstanding short interest for NANOVIBRONIX INC (NAOV) is 27.14% of its float. Check the ownership tab for more information on the NAOV short interest.
ChartMill assigns a fundamental rating of 2 / 10 to NAOV. While NAOV seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months NAOV reported a non-GAAP Earnings per Share(EPS) of -1.25. The EPS increased by 59.51% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -65.93% | ||
ROE | -164.9% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to NAOV. The Buy consensus is the average rating of analysts ratings from 7 analysts.